- Published on
Toxicology – Cone Snail Envenomation
Source
Cone snails are marine predators found in warm and tropical oceans worldwide. There are hundreds of species, many with brightly patterned shells. They use a specialized harpoon-like structure (radula) to inject venom into prey or humans when handled.
Typical Presentation
Exposure typically occurs when a person handles or steps on a cone snail. Patients often report an immediate stinging or burning sensation at the site of contact, followed by progressive neurological symptoms.
Clinical Features
Initial symptoms include localized pain similar to an insect sting, along with burning, numbness, and tingling. As toxicity progresses, patients may develop muscle weakness, difficulty swallowing, blurred vision, and spreading numbness (including lips and tongue). Severe cases can lead to paralysis, shock, and respiratory failure. Some systemic effects may be delayed.
Mechanism of Action
Cone snail venom contains a mixture of peptide toxins known as conotoxins. These compounds primarily affect ion channels and disrupt nerve signaling, leading to neuromuscular dysfunction and paralysis.
Management
There is no specific antidote. Treatment is supportive, with close monitoring of airway and respiratory function. Mechanical ventilation may be required in severe cases until the toxin is cleared. Most symptoms improve within several hours.
Key Points
- Even minor contact can result in envenomation.
- Symptoms may progress from local pain to life-threatening paralysis.
- Some conotoxins are being studied for potential medical applications.
- Although rare, fatalities have been reported.
- Published on
Toxicology – Insulin Overdose
Source
Insulin is used in various formulations for the management of diabetes mellitus. These include rapid-acting types (e.g., aspart, lispro, glulisine), short-acting (regular insulin), intermediate-acting (NPH), and long-acting forms (e.g., glargine, detemir). Each differs in onset and duration of action.
Typical Presentation
Patients may present after intentional or accidental overdose, often with altered consciousness. Severe cases may involve seizures or coma due to profound hypoglycemia.
Clinical Features
The primary manifestation is hypoglycemia, which can present with sweating, tachycardia, tremors, confusion, seizures, or coma. Some individuals may tolerate low glucose levels with minimal symptoms, while others deteriorate rapidly. Electrolyte abnormalities such as low potassium and magnesium may lead to cardiac arrhythmias. Additional findings may include hypothermia and, in severe cases, focal neurological deficits that can mimic stroke. Pulmonary edema and low phosphate levels have also been reported in significant overdoses.
Mechanism of Action
Insulin promotes the uptake of glucose into cells, particularly in the liver, muscle, and adipose tissue. Excess insulin leads to a rapid drop in blood glucose levels. The duration and severity of hypoglycemia depend on the type and amount of insulin administered.
Management
Immediate treatment involves administration of intravenous dextrose (e.g., D50) to rapidly correct hypoglycemia and restore neurological function. Continuous glucose monitoring with frequent checks is essential. Ongoing intravenous dextrose infusion may be required, along with correction of electrolyte imbalances.
Key Points
Source
Insulin is used in various formulations for the management of diabetes mellitus. These include rapid-acting types (e.g., aspart, lispro, glulisine), short-acting (regular insulin), intermediate-acting (NPH), and long-acting forms (e.g., glargine, detemir). Each differs in onset and duration of action.
Typical Presentation
Patients may present after intentional or accidental overdose, often with altered consciousness. Severe cases may involve seizures or coma due to profound hypoglycemia.
Clinical Features
The primary manifestation is hypoglycemia, which can present with sweating, tachycardia, tremors, confusion, seizures, or coma. Some individuals may tolerate low glucose levels with minimal symptoms, while others deteriorate rapidly. Electrolyte abnormalities such as low potassium and magnesium may lead to cardiac arrhythmias. Additional findings may include hypothermia and, in severe cases, focal neurological deficits that can mimic stroke. Pulmonary edema and low phosphate levels have also been reported in significant overdoses.
Mechanism of Action
Insulin promotes the uptake of glucose into cells, particularly in the liver, muscle, and adipose tissue. Excess insulin leads to a rapid drop in blood glucose levels. The duration and severity of hypoglycemia depend on the type and amount of insulin administered.
Management
Immediate treatment involves administration of intravenous dextrose (e.g., D50) to rapidly correct hypoglycemia and restore neurological function. Continuous glucose monitoring with frequent checks is essential. Ongoing intravenous dextrose infusion may be required, along with correction of electrolyte imbalances.
Key Points
- Large or subcutaneous injections may create a “depot effect,” leading to prolonged hypoglycemia.
- Delayed absorption can result in recurrent or persistent symptoms.
- Early treatment is critical; prolonged hypoglycemia worsens prognosis.
- Elevated C-peptide levels suggest endogenous insulin production rather than exogenous overdose.
- Published on
Toxicology – Baclofen Toxicity
Source
Baclofen is a prescription muscle relaxant used to treat spasticity in conditions such as spinal cord injury, cerebral palsy, and multiple sclerosis. It is available in oral form and can also be administered via intrathecal pumps for targeted delivery.
Typical Presentation
Toxicity may occur following overdose or misuse. Patients often present with progressive central nervous system depression, which may initially resemble intoxication and later advance to severe neurological impairment.
Clinical Features
Findings are consistent with a sedative-hypnotic toxidrome. Symptoms include drowsiness, poor coordination, ataxia, slurred speech, nausea, vomiting, and altered mental status. Cardiovascular effects may include either low or high blood pressure and slow or fast heart rate. Neurologically, decreased reflexes, muscle relaxation, coma, seizures, apnea, and respiratory arrest can occur. In some cases, paradoxical muscle rigidity or spasms may be seen. Severe toxicity is more likely with large ingestions and may require prolonged intensive care support.
Mechanism of Action
Baclofen acts as a GABA(B) receptor agonist, producing inhibitory effects within the central nervous system. Abrupt discontinuation after chronic use can lead to a withdrawal syndrome similar to that seen with alcohol or benzodiazepines.
Management
Treatment is supportive, with close monitoring of airway, breathing, and circulation. Mechanical ventilation may be required in cases of significant respiratory depression.
Key Points
Source
Baclofen is a prescription muscle relaxant used to treat spasticity in conditions such as spinal cord injury, cerebral palsy, and multiple sclerosis. It is available in oral form and can also be administered via intrathecal pumps for targeted delivery.
Typical Presentation
Toxicity may occur following overdose or misuse. Patients often present with progressive central nervous system depression, which may initially resemble intoxication and later advance to severe neurological impairment.
Clinical Features
Findings are consistent with a sedative-hypnotic toxidrome. Symptoms include drowsiness, poor coordination, ataxia, slurred speech, nausea, vomiting, and altered mental status. Cardiovascular effects may include either low or high blood pressure and slow or fast heart rate. Neurologically, decreased reflexes, muscle relaxation, coma, seizures, apnea, and respiratory arrest can occur. In some cases, paradoxical muscle rigidity or spasms may be seen. Severe toxicity is more likely with large ingestions and may require prolonged intensive care support.
Mechanism of Action
Baclofen acts as a GABA(B) receptor agonist, producing inhibitory effects within the central nervous system. Abrupt discontinuation after chronic use can lead to a withdrawal syndrome similar to that seen with alcohol or benzodiazepines.
Management
Treatment is supportive, with close monitoring of airway, breathing, and circulation. Mechanical ventilation may be required in cases of significant respiratory depression.
Key Points
- High doses are associated with severe CNS depression, seizures, and prolonged coma.
- Baclofen toxicity can sometimes mimic brain death.
- The drug has potential for misuse due to its sedative and euphoric effects.
- Intrathecal administration requires much smaller doses compared to oral use.
- Published on
Toxicology – Carisoprodol Toxicity
Source
Carisoprodol is a centrally acting skeletal muscle relaxant, often prescribed alone or in combination with other agents such as aspirin or codeine. It has a relatively rapid onset (about 30 minutes) and a short duration of action. The drug is metabolized into meprobamate, an active compound with sedative properties.
Typical Presentation
Patients may present with overdose or misuse, often in combination with other substances such as opioids or alcohol. Requests for specific medications and recurrent visits may raise suspicion for misuse.
Clinical Features
Toxicity produces features of a sedative-hypnotic syndrome. Symptoms include central nervous system depression, drowsiness, poor coordination, ataxia, slurred speech, nausea, vomiting, hypotension, and bradycardia. Severe cases may progress to coma, seizures, respiratory depression, or arrest. Some patients may paradoxically exhibit increased muscle tone, hyperreflexia, or abnormal posturing.
Mechanism of Action
Carisoprodol and its metabolite meprobamate enhance activity at GABA(A) receptors, producing sedative effects similar to barbiturates. Abrupt discontinuation after chronic use can lead to withdrawal symptoms resembling those seen with alcohol or benzodiazepines.
Management
Treatment is supportive, with attention to airway protection, breathing, and circulation. Monitoring is essential, especially in cases of suspected coingestion with other central nervous system depressants.
Key Points
Source
Carisoprodol is a centrally acting skeletal muscle relaxant, often prescribed alone or in combination with other agents such as aspirin or codeine. It has a relatively rapid onset (about 30 minutes) and a short duration of action. The drug is metabolized into meprobamate, an active compound with sedative properties.
Typical Presentation
Patients may present with overdose or misuse, often in combination with other substances such as opioids or alcohol. Requests for specific medications and recurrent visits may raise suspicion for misuse.
Clinical Features
Toxicity produces features of a sedative-hypnotic syndrome. Symptoms include central nervous system depression, drowsiness, poor coordination, ataxia, slurred speech, nausea, vomiting, hypotension, and bradycardia. Severe cases may progress to coma, seizures, respiratory depression, or arrest. Some patients may paradoxically exhibit increased muscle tone, hyperreflexia, or abnormal posturing.
Mechanism of Action
Carisoprodol and its metabolite meprobamate enhance activity at GABA(A) receptors, producing sedative effects similar to barbiturates. Abrupt discontinuation after chronic use can lead to withdrawal symptoms resembling those seen with alcohol or benzodiazepines.
Management
Treatment is supportive, with attention to airway protection, breathing, and circulation. Monitoring is essential, especially in cases of suspected coingestion with other central nervous system depressants.
Key Points
- Frequently abused due to its sedative and euphoric effects.
- Often taken in combination with opioids or alcohol, increasing risk of severe toxicity.
- Withdrawal can occur with abrupt cessation after prolonged use.
- Published on
Toxicology – Nonsteroidal Anti-Inflammatory Drug (NSAID) Toxicity
Source
NSAIDs are widely used medications for pain relief, inflammation, and fever reduction. Ibuprofen is the most commonly encountered agent. Other examples include diclofenac, naproxen, indomethacin, ketorolac, meloxicam, and sulindac.
Typical Presentation
Most cases involve mild overdose, often in young individuals, presenting with gastrointestinal discomfort. Severe toxicity is uncommon but may occur with large ingestions.
Clinical Features
Symptoms are usually mild and include abdominal pain, nausea, and vomiting. Occasionally, patients may develop gastrointestinal bleeding. In more severe overdoses, complications can include acute kidney injury, hyperkalemia, tinnitus, seizures, coma, or cardiovascular collapse. Symptoms typically begin within a few hours of ingestion and resolve within 24 hours in uncomplicated cases.
Mechanism of Action
NSAIDs inhibit cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin production. While this provides therapeutic effects, it can also impair kidney function and damage the gastrointestinal lining, especially with high doses or prolonged use.
Management
Treatment is supportive. Intravenous fluids and antiemetics are commonly used. There is no specific antidote. Patients with mild symptoms and stable vital signs may be observed for several hours and discharged if no complications develop.
Key Points
Source
NSAIDs are widely used medications for pain relief, inflammation, and fever reduction. Ibuprofen is the most commonly encountered agent. Other examples include diclofenac, naproxen, indomethacin, ketorolac, meloxicam, and sulindac.
Typical Presentation
Most cases involve mild overdose, often in young individuals, presenting with gastrointestinal discomfort. Severe toxicity is uncommon but may occur with large ingestions.
Clinical Features
Symptoms are usually mild and include abdominal pain, nausea, and vomiting. Occasionally, patients may develop gastrointestinal bleeding. In more severe overdoses, complications can include acute kidney injury, hyperkalemia, tinnitus, seizures, coma, or cardiovascular collapse. Symptoms typically begin within a few hours of ingestion and resolve within 24 hours in uncomplicated cases.
Mechanism of Action
NSAIDs inhibit cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin production. While this provides therapeutic effects, it can also impair kidney function and damage the gastrointestinal lining, especially with high doses or prolonged use.
Management
Treatment is supportive. Intravenous fluids and antiemetics are commonly used. There is no specific antidote. Patients with mild symptoms and stable vital signs may be observed for several hours and discharged if no complications develop.
Key Points
- Most acute NSAID overdoses are mild and self-limiting.
- Serious toxicity is more likely with very high doses (e.g., >400 mg/kg).
- Use caution in elderly patients and those with kidney disease, even at normal doses.
- Chronic overuse increases the risk of gastrointestinal bleeding and renal injury.
- Published on
Toxicology – Salicylate Toxicity
Source
Salicylates are present in many over-the-counter and prescription medications used for pain, fever, and inflammation. Common sources include aspirin, methyl salicylate (oil of wintergreen), combination cold remedies, topical analgesics, bismuth subsalicylate (e.g., Pepto-Bismol), and effervescent formulations like Alka-Seltzer.
Typical Presentation
Toxicity may occur acutely after a large ingestion or chronically from repeated high dosing, especially in elderly patients. Acute cases often present with gastrointestinal and auditory symptoms, whereas chronic toxicity may present more subtly.
Clinical Features
Acute Toxicity
Patients commonly develop nausea, vomiting, abdominal pain, rapid breathing (tachypnea), ringing in the ears (tinnitus), and confusion. Severe cases may progress to hypoglycemia, seizures, pulmonary edema, and coma. A classic finding is a mixed acid–base disorder: respiratory alkalosis combined with metabolic acidosis.
Chronic Toxicity
Typically seen in older individuals, presenting with confusion, dehydration, and metabolic acidosis. Symptoms are often nonspecific and can mimic other illnesses, making diagnosis more challenging.
Mechanism of Action
Salicylates stimulate the respiratory center in the brain, causing hyperventilation and respiratory alkalosis. They also uncouple oxidative phosphorylation, leading to increased acid production and metabolic acidosis. Additionally, they irreversibly inhibit cyclooxygenase (COX) enzymes.
Management
Treatment is supportive and includes careful monitoring. If intubation is required, maintaining adequate hyperventilation is critical to prevent worsening acidosis. Sodium bicarbonate is administered to alkalinize the blood (target pH ≥7.4) and urine (target pH 7.5–8.5), which enhances salicylate elimination.
Gastrointestinal decontamination with multiple-dose activated charcoal or whole bowel irrigation may be considered. Hemodialysis is indicated in severe toxicity, particularly with high salicylate levels or significant clinical deterioration. Patients should also be monitored for complications such as pulmonary edema.
Key Points
Source
Salicylates are present in many over-the-counter and prescription medications used for pain, fever, and inflammation. Common sources include aspirin, methyl salicylate (oil of wintergreen), combination cold remedies, topical analgesics, bismuth subsalicylate (e.g., Pepto-Bismol), and effervescent formulations like Alka-Seltzer.
Typical Presentation
Toxicity may occur acutely after a large ingestion or chronically from repeated high dosing, especially in elderly patients. Acute cases often present with gastrointestinal and auditory symptoms, whereas chronic toxicity may present more subtly.
Clinical Features
Acute Toxicity
Patients commonly develop nausea, vomiting, abdominal pain, rapid breathing (tachypnea), ringing in the ears (tinnitus), and confusion. Severe cases may progress to hypoglycemia, seizures, pulmonary edema, and coma. A classic finding is a mixed acid–base disorder: respiratory alkalosis combined with metabolic acidosis.
Chronic Toxicity
Typically seen in older individuals, presenting with confusion, dehydration, and metabolic acidosis. Symptoms are often nonspecific and can mimic other illnesses, making diagnosis more challenging.
Mechanism of Action
Salicylates stimulate the respiratory center in the brain, causing hyperventilation and respiratory alkalosis. They also uncouple oxidative phosphorylation, leading to increased acid production and metabolic acidosis. Additionally, they irreversibly inhibit cyclooxygenase (COX) enzymes.
Management
Treatment is supportive and includes careful monitoring. If intubation is required, maintaining adequate hyperventilation is critical to prevent worsening acidosis. Sodium bicarbonate is administered to alkalinize the blood (target pH ≥7.4) and urine (target pH 7.5–8.5), which enhances salicylate elimination.
Gastrointestinal decontamination with multiple-dose activated charcoal or whole bowel irrigation may be considered. Hemodialysis is indicated in severe toxicity, particularly with high salicylate levels or significant clinical deterioration. Patients should also be monitored for complications such as pulmonary edema.
Key Points
- Chronic toxicity is often missed due to nonspecific symptoms.
- Mixed respiratory alkalosis and metabolic acidosis is a hallmark finding.
- Oil of wintergreen is highly concentrated and potentially lethal, especially in children.
- Chronic toxicity generally carries a worse prognosis than acute overdose.
- Adequate ventilation must be maintained in intubated patients.
- Published on
Toxicology – Fire Ant (Formicidae) Envenomation
Source
Ants belong to the Formicidae family within the Hymenoptera order. Fire ants, particularly the red imported fire ant (RIFA), are an aggressive invasive species commonly found in the southern United States. These ants live in large, highly organized colonies and can attack in groups when disturbed.
Typical Presentation
Envenomation typically occurs when a person disturbs an ant mound, leading to multiple simultaneous stings. Victims often report sudden intense burning pain followed by visible skin lesions.
Clinical Features
Each sting produces immediate pain and a small raised wheal. Within 24 hours, these lesions evolve into characteristic pustules. The affected areas are often itchy, and scratching may lead to secondary infection or scarring. In some individuals, especially those with hypersensitivity, systemic allergic reactions including anaphylaxis may occur.
Mechanism of Action
Fire ant venom contains alkaloid compounds, particularly piperidine derivatives, which cause local tissue irritation and inflammation. The venom also includes components capable of triggering allergic responses in susceptible individuals.
Management
Treatment involves removal from the exposure source and supportive care. Topical corticosteroids and oral antihistamines can help relieve inflammation and itching. In cases of allergic reactions, appropriate management—including epinephrine for anaphylaxis—should be initiated. Antibiotics may be required if secondary infection develops.
Key Points
Source
Ants belong to the Formicidae family within the Hymenoptera order. Fire ants, particularly the red imported fire ant (RIFA), are an aggressive invasive species commonly found in the southern United States. These ants live in large, highly organized colonies and can attack in groups when disturbed.
Typical Presentation
Envenomation typically occurs when a person disturbs an ant mound, leading to multiple simultaneous stings. Victims often report sudden intense burning pain followed by visible skin lesions.
Clinical Features
Each sting produces immediate pain and a small raised wheal. Within 24 hours, these lesions evolve into characteristic pustules. The affected areas are often itchy, and scratching may lead to secondary infection or scarring. In some individuals, especially those with hypersensitivity, systemic allergic reactions including anaphylaxis may occur.
Mechanism of Action
Fire ant venom contains alkaloid compounds, particularly piperidine derivatives, which cause local tissue irritation and inflammation. The venom also includes components capable of triggering allergic responses in susceptible individuals.
Management
Treatment involves removal from the exposure source and supportive care. Topical corticosteroids and oral antihistamines can help relieve inflammation and itching. In cases of allergic reactions, appropriate management—including epinephrine for anaphylaxis—should be initiated. Antibiotics may be required if secondary infection develops.
Key Points
- Fire ant stings often occur in clusters due to coordinated attacks.
- Lesions typically progress from wheals to pustules within a day.
- Scratching increases the risk of infection and scarring.
- Severe allergic reactions, although less common, can be life-threatening.
- Published on
Toxicology – Calcium Channel Blocker Toxicity
Source
Calcium channel blockers (CCBs) include medications such as verapamil, diltiazem, amlodipine, nifedipine, nicardipine, and felodipine. These drugs are commonly prescribed for conditions like hypertension, arrhythmias, angina, migraines, and Raynaud’s phenomenon.
Typical Presentation
Toxicity often occurs after accidental ingestion, especially in children, or intentional overdose. Patients may present with cardiovascular instability along with gastrointestinal symptoms.
Clinical Features
Key findings include bradycardia, varying degrees of heart block, hypotension, nausea, vomiting, constipation, and ileus. Hyperglycemia is a distinguishing feature due to impaired insulin release. Severe cases may involve altered mental status secondary to reduced cerebral perfusion.
Mechanism of Action
CCBs inhibit L-type calcium channels in cardiac and smooth muscle. In vascular smooth muscle, this leads to vasodilation and hypotension. In the heart, they decrease sinoatrial and atrioventricular nodal conduction (negative chronotropic effect) and reduce contractility (negative inotropic effect). In pancreatic cells, calcium channel blockade decreases insulin secretion, resulting in elevated blood glucose levels.
Management
Treatment is supportive and requires close cardiac monitoring. Interventions may include intravenous fluids, calcium (calcium gluconate or calcium chloride), high-dose insulin therapy with glucose supplementation, glucagon, vasopressors, and lipid emulsion therapy in severe cases. Whole bowel irrigation may be considered for sustained-release ingestions. Advanced measures such as transvenous pacing or intra-aortic balloon pump support may be required in refractory cases.
Key Points
Source
Calcium channel blockers (CCBs) include medications such as verapamil, diltiazem, amlodipine, nifedipine, nicardipine, and felodipine. These drugs are commonly prescribed for conditions like hypertension, arrhythmias, angina, migraines, and Raynaud’s phenomenon.
Typical Presentation
Toxicity often occurs after accidental ingestion, especially in children, or intentional overdose. Patients may present with cardiovascular instability along with gastrointestinal symptoms.
Clinical Features
Key findings include bradycardia, varying degrees of heart block, hypotension, nausea, vomiting, constipation, and ileus. Hyperglycemia is a distinguishing feature due to impaired insulin release. Severe cases may involve altered mental status secondary to reduced cerebral perfusion.
Mechanism of Action
CCBs inhibit L-type calcium channels in cardiac and smooth muscle. In vascular smooth muscle, this leads to vasodilation and hypotension. In the heart, they decrease sinoatrial and atrioventricular nodal conduction (negative chronotropic effect) and reduce contractility (negative inotropic effect). In pancreatic cells, calcium channel blockade decreases insulin secretion, resulting in elevated blood glucose levels.
Management
Treatment is supportive and requires close cardiac monitoring. Interventions may include intravenous fluids, calcium (calcium gluconate or calcium chloride), high-dose insulin therapy with glucose supplementation, glucagon, vasopressors, and lipid emulsion therapy in severe cases. Whole bowel irrigation may be considered for sustained-release ingestions. Advanced measures such as transvenous pacing or intra-aortic balloon pump support may be required in refractory cases.
Key Points
- Mental status may initially remain normal despite significant cardiovascular compromise.
- Hyperglycemia helps differentiate CCB toxicity from beta-blocker overdose.
- ECG findings may include PR prolongation, sinus arrest, or high-grade heart block.
- Atropine may be attempted for bradycardia but is often ineffective.
- Published on
Toxicology – Beta-Blocker Toxicity
Source
Beta-blockers include medications such as propranolol, metoprolol, atenolol, nadolol, pindolol, labetalol, and carvedilol. These drugs are commonly used to manage hypertension, cardiac arrhythmias, angina, migraines, and anxiety-related conditions.
Typical Presentation
Toxicity may occur after accidental ingestion (especially in children) or intentional overdose. Patients often present with cardiovascular depression and altered mental status.
Clinical Features
Common findings include bradycardia, hypotension, and varying degrees of heart block. More severe toxicity may lead to ventricular arrhythmias, seizures (especially with propranolol), and central nervous system depression. Additional features can include widened QRS complexes (notably with propranolol), QT prolongation (e.g., with sotalol), and hypoglycemia.
Mechanism of Action
Beta-blockers inhibit β-adrenergic receptors. Blockade of β1 receptors reduces heart rate and contractility, leading to decreased cardiac output. β2 receptor blockade can result in bronchoconstriction. Lipophilic agents, particularly propranolol, cross the blood–brain barrier and can cause central nervous system effects such as sedation, confusion, and seizures.
Management
Treatment is supportive with continuous cardiac monitoring. Interventions may include intravenous fluids, glucagon (to increase intracellular cAMP independent of β-receptors), high-dose insulin therapy with glucose, vasopressors, and cardiac pacing if needed. Sodium bicarbonate may be used for QRS widening, and magnesium for QT prolongation. Lipid emulsion therapy can be considered in severe cases. Bronchodilators are used if bronchospasm develops. Whole bowel irrigation may be indicated for sustained-release ingestions.
Key Points
Source
Beta-blockers include medications such as propranolol, metoprolol, atenolol, nadolol, pindolol, labetalol, and carvedilol. These drugs are commonly used to manage hypertension, cardiac arrhythmias, angina, migraines, and anxiety-related conditions.
Typical Presentation
Toxicity may occur after accidental ingestion (especially in children) or intentional overdose. Patients often present with cardiovascular depression and altered mental status.
Clinical Features
Common findings include bradycardia, hypotension, and varying degrees of heart block. More severe toxicity may lead to ventricular arrhythmias, seizures (especially with propranolol), and central nervous system depression. Additional features can include widened QRS complexes (notably with propranolol), QT prolongation (e.g., with sotalol), and hypoglycemia.
Mechanism of Action
Beta-blockers inhibit β-adrenergic receptors. Blockade of β1 receptors reduces heart rate and contractility, leading to decreased cardiac output. β2 receptor blockade can result in bronchoconstriction. Lipophilic agents, particularly propranolol, cross the blood–brain barrier and can cause central nervous system effects such as sedation, confusion, and seizures.
Management
Treatment is supportive with continuous cardiac monitoring. Interventions may include intravenous fluids, glucagon (to increase intracellular cAMP independent of β-receptors), high-dose insulin therapy with glucose, vasopressors, and cardiac pacing if needed. Sodium bicarbonate may be used for QRS widening, and magnesium for QT prolongation. Lipid emulsion therapy can be considered in severe cases. Bronchodilators are used if bronchospasm develops. Whole bowel irrigation may be indicated for sustained-release ingestions.
Key Points
- Lipophilic beta-blockers can cause early and significant central nervous system depression.
- Hypoglycemia is more commonly seen compared to calcium channel blocker toxicity.
- Bronchospasm may occur, particularly in patients with underlying respiratory disease.
- Published on
Toxicology – Hymenoptera Envenomation (Bees, Wasps, Hornets)
Source
Hymenoptera are winged insects that include bees, wasps, hornets, and ants. The Vespidae family (wasps, yellow jackets, hornets) tend to be more aggressive, while the Apidae family (honeybees, bumblebees) are generally less aggressive unless provoked.
Typical Presentation
Patients may present after one or multiple stings, often occurring outdoors. Severe reactions are more likely in cases of multiple stings or in individuals with allergic sensitivity.
Clinical Features
Local reactions include pain, redness, swelling, and warmth at the sting site. Systemic reactions may involve widespread hives (urticaria), wheezing, shortness of breath, chest discomfort, nausea, vomiting, airway swelling (stridor), altered mental status, and in severe cases, shock or coagulopathy. Anaphylaxis can occur even after a single sting in sensitized individuals.
Mechanism of Action
Venom from these insects contains substances such as melittin, histamine, phospholipases, and other mediators that trigger inflammation and mast cell activation. This can lead to allergic reactions ranging from mild to life-threatening.
Management
Treatment is supportive. Any retained stingers should be promptly removed by scraping to prevent further venom release. Anaphylaxis requires immediate administration of epinephrine. Additional therapies may include antihistamines, corticosteroids, intravenous fluids, and inhaled beta-agonists for respiratory symptoms.
Key Points
Source
Hymenoptera are winged insects that include bees, wasps, hornets, and ants. The Vespidae family (wasps, yellow jackets, hornets) tend to be more aggressive, while the Apidae family (honeybees, bumblebees) are generally less aggressive unless provoked.
Typical Presentation
Patients may present after one or multiple stings, often occurring outdoors. Severe reactions are more likely in cases of multiple stings or in individuals with allergic sensitivity.
Clinical Features
Local reactions include pain, redness, swelling, and warmth at the sting site. Systemic reactions may involve widespread hives (urticaria), wheezing, shortness of breath, chest discomfort, nausea, vomiting, airway swelling (stridor), altered mental status, and in severe cases, shock or coagulopathy. Anaphylaxis can occur even after a single sting in sensitized individuals.
Mechanism of Action
Venom from these insects contains substances such as melittin, histamine, phospholipases, and other mediators that trigger inflammation and mast cell activation. This can lead to allergic reactions ranging from mild to life-threatening.
Management
Treatment is supportive. Any retained stingers should be promptly removed by scraping to prevent further venom release. Anaphylaxis requires immediate administration of epinephrine. Additional therapies may include antihistamines, corticosteroids, intravenous fluids, and inhaled beta-agonists for respiratory symptoms.
Key Points
- These stings are a leading cause of fatal envenomation, primarily due to anaphylaxis.
- Severe reactions can occur even with a single sting in allergic individuals.
- Honeybees typically leave behind a barbed stinger, whereas wasps and hornets can sting multiple times.
